Wonbiogen Co (XKRX:307280) Net Change in Cash : ₩4,159 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Wonbiogen Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Wonbiogen Co's Net Change in Cash for the three months ended in Dec. 2024 was ₩4,537 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩4,159 Mil.

Wonbiogen Co Net Change in Cash Historical Data

The historical data trend for Wonbiogen Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wonbiogen Co Net Change in Cash Chart

Wonbiogen Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

40.20

5,173.33

-4,445.04

-189.86

4,159.42

Wonbiogen Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															818.18	-837.57	1,176.38	-716.24	4,536.85

Wonbiogen Co Net Change in Cash Calculation

Wonbiogen Co's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	8849.517	+	2427.446	+	-7185.551	+	68.005
	=	4,159

Wonbiogen Co's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 2500.551 + 7631.132 + -5693.5 + 98.669

= 4,537

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,159 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wonbiogen Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Wonbiogen Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Wonbiogen Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wonbiogen Co Ltd (XKRX:307280) » Definitions » Net Change in Cash

Comparable Companies

XKRX:049180 XKRX:246720 XKRX:450330 XKRX:261200 XKRX:059210 XKRX:303810 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST ALGN

Traded in Other Exchanges

N/A

Address

56, 1 Gongdan-ro 5-gil, Gyeongsangbuk-do, Gumi-si, KOR

Website

http://www.wonbiogen.co.kr

Wonbiogen Co Ltd is engaged in the manufacturing of medical supplies and instruments. Its product portfolio comprises Therasorb Algi Adhesive, Therasorb AD, Renoderm, Remscar Gel, Meditouch Liquid, and Meditouch Bend, among others.

Wonbiogen Co Headlines

No Headlines